Filter Results:
(406)
Show Results For
- All HBS Web (406)
- Faculty Publications (77)
Show Results For
- All HBS Web (406)
- Faculty Publications (77)
- November 2020
- Case
Valuing Celgene's CVR
By: Benjamin C. Esty and Daniel Fisher
When Bristol-Myers Squibb (BMS) acquired Celgene Corporation in November 2019, Celgene shareholders received cash, BMS stock, and a contingent value right (CVRs) that would pay $9 if the U.S. Food and Drug Administration (FDA) approved three of Celgene’s late stage... View Details
Keywords: Mergers and Acquisitions; Value; Valuation; Judgments; Decision Making; Cash Flow; Financial Instruments; Cognition and Thinking; Pharmaceutical Industry; Biotechnology Industry; United States
Esty, Benjamin C., and Daniel Fisher. "Valuing Celgene's CVR." Harvard Business School Case 221-031, November 2020.
- 13 Sep 2006
- Op-Ed
Rising CEO Pay: What Directors Should Do
Ask any thoughtful corporate board member what they are most concerned about these days, and it is not Sarbanes-Oxley. It is CEO pay. Directors worry because shareholders continue to express outrage, and the media attention to the issue... View Details
Keywords: by Jay W. Lorsch
- October 14, 2019
- Article
A Guide to the Big Ideas and Debates in Corporate Governance
By: Lynn S. Paine and Suraj Srinivasan
How corporations govern themselves has become a matter of broad public interest in recent decades. Amid this many commentators and experts still disagree on such basic matters as the purpose of the corporation, the role of corporate boards of directors, the rights of... View Details
Keywords: Corporate Governance; Mission and Purpose; Governing and Advisory Boards; Business and Shareholder Relations; Performance; Measurement and Metrics
Paine, Lynn S., and Suraj Srinivasan. "A Guide to the Big Ideas and Debates in Corporate Governance." Harvard Business Review (website) (October 14, 2019).
A Guide to the Big Ideas and Debates in Corporate Governance
How corporations govern themselves has become a matter of broad public interest in recent decades. Amid this many commentators and experts still disagree on such basic matters as the purpose of the corporation, the role of corporate boards of directors, the... View Details
- April 2016 (Revised June 2017)
- Teaching Note
Dollar General Bids for Family Dollar
By: Jonas Heese, Paula A. Price and Suraj Srinivasan
In spring 2015, Dollar General CEO Rick Dreiling was looking ahead to retiring at year's end but worried about ensuring continued growth for the company he had built since 2008 into a market leader in the U.S. discount retail world. Dollar General operated over 11,500... View Details
- 25 Feb 2014
- First Look
First Look: February 25
between the Institutional Shareholder Services and management regarding the appropriateness of the CEO's compensation plan. Was ISS right that Qualcomm CEO's pay was inflated and justified by benchmarking to... View Details
Keywords: Sean Silverthorne
- November 2015 (Revised October 2017)
- Case
Dollar General Bids for Family Dollar
By: Jonas Heese, Paula A. Price, Suraj Srinivasan and David Lane
In spring 2015, Dollar General's CEO Rick Dreiling was looking ahead to retiring at year's end but worried about ensuring continued growth for the company he had built since 2008 into a market leader in the U.S. discount retail world. Dollar General operated over... View Details
Keywords: Dollar General; Family Dollar; Dollar Tree; Antitrust; Board Of Directors; Activist Investors; Federal Trade Commission; Acquisition; Valuation; Corporate Strategy; Retail Industry; United States
Heese, Jonas, Paula A. Price, Suraj Srinivasan, and David Lane. "Dollar General Bids for Family Dollar." Harvard Business School Case 116-007, November 2015. (Revised October 2017.)
- 30 Jan 2017
- Research & Ideas
Vanguard, Trian And The Problem With 'Passive' Index Funds
shareholders more engaged? What shape should the separation of management and ownership take in the twenty-first century? These are hugely important questions playing out live right now,” he says. The case... View Details
- October 2016 (Revised October 2017)
- Case
Misaki Capital and Sangetsu Corporation
By: Ian Gow, Charles C.Y. Wang, Naoko Jinjo and Nobuo Sato
Japan’s corporate culture has traditionally prioritized the interests of stakeholders such as customers, employees, and suppliers over those of shareholders. After a decades-long economic slump, Japan’s government has revitalized efforts to improve corporate governance... View Details
Keywords: Activist Investing; Constructivist Investing; Japan; Valuation; Stock Screens; Return On Equity; Investment; Business and Stakeholder Relations; Corporate Governance; Financial Strategy; Business and Shareholder Relations; Japan
Gow, Ian, Charles C.Y. Wang, Naoko Jinjo, and Nobuo Sato. "Misaki Capital and Sangetsu Corporation." Harvard Business School Case 117-007, October 2016. (Revised October 2017.)
- January 2023
- Case
Rentokil: The Terminix Acquisition
By: Ted Berk, Emily R. McComb and Julia Kelley
When announcing their agreement to merge in December 2021, creating a clear leader in global pest control, UK-based Rentokil and Tennessee-based Terminix described extensive benefits of the cross-border combination. The companies touted the advantages of their combined... View Details
Keywords: Mergers and Acquisitions; Valuation; Cross-Cultural and Cross-Border Issues; Business and Shareholder Relations
Berk, Ted, Emily R. McComb, and Julia Kelley. "Rentokil: The Terminix Acquisition." Harvard Business School Case 223-061, January 2023.
- 02 Aug 2004
- What Do You Think?
For Greater Transparency, Is Section 404 an Effective Response?
transparency for shareholders and other stakeholders. The primary argument is that, without high standards of personal integrity posed from within, Section 404 will be of limited value. As John Louk put it, "I personally believe that... View Details
Keywords: by James Heskett
- 2022
- Article
Pills in a World of Activism and ESG
By: Guhan Subramanian and Caley Petrucci
Easterbrook and Fischel’s The Economic Structure of Corporate Law advances their now famous passivity thesis, which posits that managers should remain passive in the face of an unsolicited tender offer for the company’s shares. Consistent with the broader... View Details
Subramanian, Guhan, and Caley Petrucci. "Pills in a World of Activism and ESG." University of Chicago Business Law Review 1 (2022): 417–439.
- November 2020
- Supplement
Valuing Celgene's CVR
By: Benjamin C. Esty and Daniel Fisher
When Bristol-Myers Squibb (BMS) acquired Celgene Corporation in November 2019, Celgene shareholders received cash, BMS stock, and a contingent value right (CVRs) that would pay $9 if the U.S. Food and Drug Administration (FDA) approved three of Celgene’s late stage... View Details
- December 2016
- Article
Deal Process Design in Management Buyouts
Management buyouts (MBOs) are an economically and legally significant class of transaction: not only do they account for more than $10 billion in deal volume per year, on average, but they also play an important role in defining the relationship between inside and... View Details
Subramanian, Guhan. "Deal Process Design in Management Buyouts." Harvard Law Review 130, no. 2 (December 2016): 590–658.
- November 2020 (Revised February 2021)
- Case
Wes Hall and the BlackNorth Initiative
By: Shikhar Ghosh, Marilyn Morgan Westner and Reza Satchu
Wes Hall founded Kingsdale Advisors and built it into one of Canada’s leading shareholder services and advisory firms. Influenced by the Black Lives Matter (BLM) movement and a series of social injustices—specifically the death of George Floyd in police custody—Hall... View Details
Keywords: Racism; Cultural Entrepreneurship; Social Entrepreneurship; Diversity; Race; Social Issues; Ethics; Canada; North America
Ghosh, Shikhar, Marilyn Morgan Westner, and Reza Satchu. "Wes Hall and the BlackNorth Initiative." Harvard Business School Case 821-056, November 2020. (Revised February 2021.)
- August 2006 (Revised February 2009)
- Case
Medco Energi Internasional
In late 2004, Hilmi Panigoro, CEO of the publicly traded Indonesian oil company Medco Energi Internasional, is striving to regain majority control of the company his brother Arifin founded in 1980. The Asian financial crisis of 1999 led to a major restructuring that... View Details
Keywords: Leveraged Buyouts; Family Business; Restructuring; Financing and Loans; Ownership Stake; Business and Shareholder Relations; Indonesia; Singapore
Villalonga, Belen, Raphael Amit, and Christopher Hartman. "Medco Energi Internasional." Harvard Business School Case 207-021, August 2006. (Revised February 2009.)
- September 2006
- Supplement
Medco Energi Internasional (CW)
In late 2004, Hilmi Panigoro, CEO of the publicly traded Indonesian oil company Medco Energi Internasional, is striving to regain majority control of the company his brother Arifin founded in 1980. The Asian financial crisis of 1999 led to a major restructuring that... View Details
- December 2001 (Revised June 2002)
- Case
Compensation at Level 3 Communications
Level 3's unique compensation plan rewarded managers for the firm's performance only if the firm's stock price movement exceeded that of the market. This design was intended to maximize shareholder value by tying manager's performance more closely to that of the firm,... View Details
Meulbroek, Lisa K. "Compensation at Level 3 Communications." Harvard Business School Case 202-084, December 2001. (Revised June 2002.)
- 2025
- Chapter
Critical Choices in Designing a Board: An Overview
By: Suraj Srinivasan and Lynn S. Paine
Board design is never one-size-fits-all. It’s a series of critical choices—each with trade-offs—that can define how a board functions, governs, and delivers strategic value.
That’s the premise of "Critical Choices in Designing a Board," a... View Details
Keywords: Governing and Advisory Boards
Srinivasan, Suraj, and Lynn S. Paine. "Critical Choices in Designing a Board: An Overview." Chap. 3 in NYSE & JP Morgan, Public Company Series: Board Structure and Composition, edited by Joseph Hall and Stephen Byeff, 17–23. Public Company Series. Caxton Business & Legal, Inc., 2025.
- November 2020
- Teaching Note
Valuing Celgene's CVR
By: Benjamin C. Esty and Daniel Fisher
Teaching Note for HBS Case No. 221-031. When Bristol-Myers Squibb (BMS) acquired Celgene Corporation in November 2019, Celgene shareholders received cash, BMS stock, and a contingent value right (CVRs) that would pay $9 if the U.S. Food and Drug Administration (FDA)... View Details